| Sig | HR | 95% CI for HR |
---|---|---|---|
Recurrence free survival | |||
 Race | 0.791 | 1.095 | 0.560–2.140 |
 Grade | 0.34 | 1.128 | 0.881–1.445 |
 Stage | 0.000 | 1.442 | 1.247–1.667 |
 CD20 score | 0.231 | 0.72 | 0.420–1.236 |
 IgG4 | 0.001 | 3.336 | 1.607–7.0560 |
 IL-10 | 0.000 | 7.195 | 2.418–21.411 |
 IL-4 | 0.279 | 1.535 | 0.707–3.337 |
Overall survival | |||
 Race | 0.604 | 0.83 | 0.411–1.678 |
 Grade | 0.931 | 1.014 | 0.736–1.398 |
 Stage | 0.000 | 1.329 | 1.151–1.534 |
 CD20 score | 0.211 | 0.706 | 0.409–1.218 |
 IgG4 | 0.074 | 2.541 | 1.204–5.336 |
 IL-10 | 0.005 | 4.101 | 1.538–10.934 |
 IL-4 | 0.528 | 1.283 | 0.592–2.779 |